Clinical trial · Interventional
In Vitro Maturation of Human Eggs
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
CCRM Fertility, a global pioneer in fertility treatment, research and science, is seeking participants for a new study on in vitro maturation (IVM). IVM requires less hormones to stimulate the ovaries than IVF, making it more affordable than IVF with fewer side effects. Participants that qualify for the study will receive a free cycle of IVM treatment at CCRM Fertility and including a new patient consultation, fertility testing, preimplantation genetic testing for aneuploidies (PGT-A), anesthesia and some medication
Conditions
Conditions (12)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| AMH | — | UNRESOLVED | — |
| Healthy | — | UNRESOLVED | — |
| Infertility | — | UNRESOLVED | — |
| Infertility Female | — | UNRESOLVED | — |
| Infertility of Tubal Origin | — | UNRESOLVED | — |
| Infertility Poly Cystic Ovary | — | UNRESOLVED | — |
| In Vitro Maturation | — | UNRESOLVED | — |
| IVF | — | UNRESOLVED | — |
| IVM | — | UNRESOLVED | — |
| Ovarian Reserve | — | UNRESOLVED | — |
| PCOS | — | UNRESOLVED | — |
| PCOS (Polycystic Ovary Syndrome) |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| IVM | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Biphasic IVM Treatment
- description
- Biphasic IVM of oocytes
- interventionNames
- Other: IVM
Primary outcomes (3)
- measure
- Oocyte maturation
- timeFrame
- 27 hours
- description
- Maturation rate of retrieved oocytes
- measure
- Embryo fertilization and development
- timeFrame
- 7 days
- description
- Number of embryos that fertilize and develop after ICSI. Blastocysts will be biopsied and frozen on days 5, 6, and 7 of development
Eligibility
Eligibility (as posted)
- Sex
- Female
- Maximum age
- 38 Years
Show eligibility criteria text
Inclusion Criteria: * Infertile women diagnosed with PCOS or polycystic ovaries, or infertile women with good ovarian reserve * Antral follicle count (AFC) greater than 24 * AMH greater than 3.5 ng/ml * Body Mass Index less than 35 * Accept to have embryos biopsied for PGT * Intend to perform embryo transfer within 4 months after completing the IVM cycle * Paternal (or donor) age \<45, ejaculated sperm collection only (partner frozen and donor sperm acceptable), sperm morphology (strict criteria) \>1%, motility \> 20% and sperm count \> 10 million per ml (so samples can be prepared through standard procedure) Exclusion Criteria: * More than 2 failed IVF cycles
References
Publications (0)
Data not yet available